Article
17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology - 1 Aug 2012
Maier Polyana S, Mattiello Simone S, Lages Luiza, Spritzer Poli M
Abstract excerpt
We studied (1) the effects of oral contraceptive pills (OCPs) on hirsutism, hormonal and metabolic variables in 49 polycystic ovary syndrome patients without metabolic comorbidities and (2) the effect of 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) on the response to OCP treatment. Mean age was 21.9 ± 6.5 years. Patients received monophasic OCP (20 μg ethinyl estradiol plus 75 μg...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
